By age 60, more than 50 percent of men in the United States suffer from benign prostatic hyperplasia (BPH), a condition that leads to annoying changes in urinary flow. While medical therapy is usually the first line of treatment, a new minimally invasive implant can dramatically reduce symptoms for men.

“This is a safe procedure for men with BPH to improve urination while preserving sexual function,” said Mike Hsieh, MD, urologist at UC San Diego Health System. “This endoscopic procedure is done on an outpatient basis under light sedation with virtually no side effects.”

The prostate is a walnut-sized gland that sits below the bladder. When the prostate becomes enlarged, it can restrict or block urine flow causing interrupted or weak urine stream, leakage, urge incontinence and more frequent urination, especially at night.

“More than half of all men in their sixties and as many as 80 percent of men in their seventies and eighties have some symptoms of BPH,” said Hsieh. “This is an excellent alternative to traditional surgeries that require removal of prostate tissue, which can cause complications such as erectile and ejaculatory dysfunction.”

The implant is comprised of a series of tiny permanent sutures that lift the enlarged prostate open so that it does not interfere with the urethra or bladder anatomy. The implants are delivered through a hollow needle and into the prostate. No urinary catheter is needed post-procedure. Side effects may include burning and blood in the urine during the first 24 hours after the procedure.

The device, called UroLift, was FDA approved in 2013. UC San Diego Health System show-cased this new procedure in a live-surgery during the 8th annual UC San Diego School of Medicine urology postgraduate course.

Hsieh specializes in male fertility and men’s health. He treats sexual dysfunction, including low testosterone, erectile dysfunction and Peyronie’s disease. He is also a recognized expert in treating male infertility, including ejaculatory disorder, hormone imbalance, sperm production impairment and genetic causes of infertility.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is 8 times 9?

Explore More

Neuronal molecule makes prostate cancer more aggressive

Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key molecular players that drive prostate cancer

Enzyme that protects against viruses could fuel cancer evolution

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators

Loss of Y chromosome in men enables cancer to grow

As men age, some of their cells lose the very thing that makes them biological males — the Y chromosome — and this loss hampers the body’s ability to fight